<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03148951</url>
  </required_header>
  <id_info>
    <org_study_id>MANLOP</org_study_id>
    <nct_id>NCT03148951</nct_id>
  </id_info>
  <brief_title>The Relation of MPV and NLR With Postoperative Pain in Patients Undergoing Total Knee Arthroplasty</brief_title>
  <official_title>The Relation of MPV and NLR With Postoperative Pain in Patients Undergoing Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Akdeniz University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Akdeniz University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the planned study the investigators want to evaluate the relation between postoperative
      Visual Analogue Scale(VAS) scores, complications and minor/ major morbidities, mortality and
      Mean Platelet Volume (MPV) and Neutrophil/ lymphocyte (N/L) ratio.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  In this study the investigators aim to determine the relation between the MPV and N/L
           ratio and postoperative pain levels and the incidence of postoperative adverse events
           and complications in patients undergoing knee arthroplasty.

        -  In this study only the laboratory tests that are routinely used for the operative
           patients are going to be used and no extra tests will be performed. The study will begin
           after the postoperative blood samples are collected for routine laboratory measurements.
           The patients will be allocated to 4 groups according to the type of anesthesia and VAS
           scores. Preoperative and postoperative peripheral blood total whole blood MPV and N/L
           ratio and 1st 6th 12th ve 24th hours VAS scores and complications, morbidities and
           mortality will be recorded. The patients will receive analgesics according to the
           routine practice in the ward and the doses of analgesics given will be recorded at 1st
           6th 12th ve 24the hours wil be recorded.

        -  Statistical analysis: the numerical variables will be analyzed tested with
           Kolmogorov-Smirnov test for normality. For the parametric variables that are normally
           distributed t-test will be used for the comparison between groups. For the parametric
           variables that are not normally distributed Mann Whitney-U test will be used. All the
           categorical variables will be evaluated with q- square tests. A p value &lt; 0.05 will be
           determined as statistically significant.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 28, 2017</start_date>
  <completion_date type="Anticipated">July 10, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 10, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>postoperative VAS (visual analogue scale) score</measure>
    <time_frame>VAS score at postoperative twenty-forth hours will be evaluated</time_frame>
    <description>postoperative visual analog scale score for pain evaluation 0,10,20,30,40,50,60,70,80,90,100)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>analgesic drugs</measure>
    <time_frame>total dose of analgesic drugs required at twenty four hours will be evaluated</time_frame>
    <description>analgesic drugs given according to the routine practice in the ward</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative major morbidities</measure>
    <time_frame>at postoperative first, sixth, twelfth and twenty-forth hours</time_frame>
    <description>postoperative Myocardial Infarction (MI), Acute Kidney Injury(AKI), and Cerebrovascular Events (CVO)s.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>postoperative side effects</measure>
    <time_frame>at postoperative first, sixth, twelfth and twenty-forth hours</time_frame>
    <description>nausea, vomiting, abdominal pain, agitation, head ache, muscular weakness, dizziness,hiccups, bronchospasm, bradycardia, itching, urinary retention,</description>
  </other_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Knee Arthropathy</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Group 1: patients receiving general anesthesia and having a postoperative pain VAS score equal to or below 50 at 1st, 6th, 12th nd 24th hours the pain sores will be evaluated at 4 time intervals and so the number of patients in every group may change at every time interval.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Group 2: patients receiving general anesthesia and having a postoperative pain VAS score equal to or above 60 at 1st, 6th, 12th nd 24th hours the pain sores will be evaluated at 4 time intervals and so the number of patients in every group may change at every time interval.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>Group 3: patients receiving regional (spinal) anesthesia and having a postoperative pain VAS score equal to or below 50 at 1st, 6th, 12th nd 24th hours the pain sores will be evaluated at 4 time intervals and so the number of patients in every group may change at every time interval.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <description>Group 4: patients receiving spinal anesthesia and having a postoperative pain VAS score equal to or above 60 at 1st, 6th, 12th nd 24th hours the pain sores will be evaluated at 4 time intervals and so the number of patients in every group may change at every time interval.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients undergoing knee arthroplasty in 3 years period with general or
        spinal anesthesia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  knee arthroplasty patients with general or spinal anesthesia.

        Exclusion Criteria:

          -  patients not giving consent

          -  reoperations

          -  patients having inflammatory disease

          -  infection in the knee

          -  sepsis

          -  bleeding disorders

          -  hematologic diseases,

          -  using steroids.

          -  trauma

          -  fracture patients,

          -  bilateral knee prothesis

          -  combined surgery procedures

          -  patients needing perioperative transfusions

          -  uncooperative patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilker o Aycan, asso prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Akdeniz University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ilker o aycan, asso prof</last_name>
    <phone>+905056702335</phone>
    <email>ilkeraycan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nesil Coskunfirat, Asso prof</last_name>
    <phone>+905326873426</phone>
    <email>nesildgr@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AkdenizU</name>
      <address>
        <city>Antalya</city>
        <zip>07058</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilker O Aycan, Ass. Prof.</last_name>
      <phone>+905056702335</phone>
      <email>ilkeraycan@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Nesil Coskunfirat, Ass.Prof.</last_name>
      <phone>+905326873426</phone>
      <email>nesildgr@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607690/pdf/PG-10-24573.pdf</url>
    <description>The role of mean platelet volume in patients with non-specific abdominal pain in an emergency department</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750894/pdf/cmc-10-2016-019.pdf</url>
    <description>Neutrophil/Lymphocyte Ratio as a Predictor of In-Hospital Major Adverse Cardiac Events, New-Onset Atrial Fibrillation, and No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2017</study_first_submitted>
  <study_first_submitted_qc>May 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2017</study_first_posted>
  <last_update_submitted>January 29, 2018</last_update_submitted>
  <last_update_submitted_qc>January 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Akdeniz University</investigator_affiliation>
    <investigator_full_name>Ä°lker Onguc Aycan</investigator_full_name>
    <investigator_title>Associated Professor</investigator_title>
  </responsible_party>
  <keyword>MPV</keyword>
  <keyword>NLR</keyword>
  <keyword>Postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

